We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+11.79%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$534M
AUM Growth
-$21.9M
Cap. Flow
-$79.4M
Cap. Flow %
-14.86%
Top 10 Hldgs %
43.67%
Holding
341
New
6
Increased
22
Reduced
97
Closed
12

Top Buys

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$1M
2
TDOC icon
Teladoc Health
TDOC
+$518K
3
CCXI
ChemoCentryx, Inc.
CCXI
+$307K
4
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$200K
5
EGIO
Edgio, Inc. Common Stock
EGIO
+$179K

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$8.63M
2
MSFT icon
Microsoft
MSFT
+$8.52M
3
AMZN icon
Amazon
AMZN
+$7.33M
4
V icon
Visa
V
+$3.3M
5
META icon
Meta Platforms (Facebook)
META
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 32%
2 Consumer Discretionary 14.6%
3 Healthcare 14.58%
4 Financials 11.75%
5 Communication Services 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
151
IBM
IBM
$213B
$292K 0.05%
2,506
– –
EPRT icon
152
Essential Properties Realty Trust
EPRT
$6.74B
$289K 0.05%
15,562
+3,593
+30% +$60.9K
TENB icon
153
Tenable Holdings
TENB
$3.86B
$288K 0.05%
7,624
+2,470
+48% +$84.7K
PLNT icon
154
Planet Fitness
PLNT
$4.45B
$277K 0.05%
4,492
– –
LAD icon
155
Lithia Motors
LAD
$8.31B
$272K 0.05%
1,193
– –
KO icon
156
Coca-Cola
KO
$374B
$259K 0.05%
5,209
– –
MYOK
157
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$257K 0.05%
+1,885
New +$200K
RH icon
158
RH
RH
$3.29B
$253K 0.05%
660
– –
INSM icon
159
Insmed
INSM
$21.3B
$251K 0.05%
7,813
– –
FORM icon
160
FormFactor
FORM
$8.48B
$250K 0.05%
10,018
+6,204
+163% +$173K
PM icon
161
Philip Morris
PM
$292B
$245K 0.05%
3,212
– –
MO icon
162
Altria Group
MO
$114B
$236K 0.04%
5,966
– –
LLY icon
163
Eli Lilly
LLY
$1,000B
$235K 0.04%
1,586
– –
TSEM icon
164
Tower Semiconductor
TSEM
$26.5B
$229K 0.04%
12,576
+2,175
+21% +$43.9K
FOLD
165
DELISTED
Amicus Therapeutics
FOLD
$228K 0.04%
16,168
+5,442
+51% +$79.3K
BCO icon
166
Brink's
BCO
$4.76B
$225K 0.04%
5,465
– –
AGYS icon
167
Agilysys
AGYS
$3.09B
$218K 0.04%
9,012
– –
NMIH icon
168
NMI Holdings
NMIH
$3.35B
$215K 0.04%
12,092
– –
ESNT icon
169
Essent Group
ESNT
$6.15B
$211K 0.04%
5,699
– –
AVGO icon
170
Broadcom
AVGO
$1.87T
$207K 0.04%
5,670
– –
AGG icon
171
iShares Core US Aggregate Bond ETF
AGG
$137B
$206K 0.04%
1,747
– –
AMED
172
DELISTED
Amedisys
AMED
$205K 0.04%
866
– –
VRNS icon
173
Varonis Systems
VRNS
$4.73B
$205K 0.04%
5,316
– –
QLYS icon
174
Qualys
QLYS
$5.45B
$204K 0.04%
2,082
+1,188
+133% +$127K
GWPH
175
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$204K 0.04%
2,095
– –
5 6
7
8 9

Similar funds

NRCM
North Reef Capital Management Laguna Beach, California $2.91B AUM 11.03% 1-Year Est. Return
BAM
BCV Asset Management Winnipeg $2.91B AUM
PFM
Potomac Fund Management Miami, Florida $2.88B AUM 15.75% 1-Year Est. Return
DMIC
Dixon Mitchell Investment Counsel Vancouver, British Columbia, Canada $2.88B AUM 18.53% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $2.87B AUM 26.77% 1-Year Est. Return
CCM
Chilton Capital Management Houston, Texas $2.87B AUM 25.44% 1-Year Est. Return
HCC
Hirtle Callaghan & Co West Conshohocken, Pennsylvania $2.92B AUM 17.65% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Silvant Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Silvant Capital Management held 341 positions worth $534M, down 3.9% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Silvant Capital Management withdrew a net $79.4M in Q3 2020, closing 12 positions and reducing 97 holdings. Its most notable exit was HealthEquity, an estimated $390K position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Silvant Capital Management opened a new position in Akamai worth $998K.

  • Silvant Capital Management's largest Q3 2020 buy was Akamai: 9,024 shares worth $998K.
  • Silvant Capital Management added most to Teladoc Health in Q3 2020, an estimated $518K increase.
  • Silvant Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $8.63M.
  • Silvant Capital Management fully exited HealthEquity in Q3 2020, selling an estimated $390K.
  • Silvant Capital Management's ten largest holdings make up 44% of its $534M portfolio in Q3 2020.
  • Silvant Capital Management opened 6 new positions and closed 12 in Q3 2020.
  • Silvant Capital Management's portfolio value fell 3.9% quarter-over-quarter to $534M.

Based on Silvant Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.